A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
4–11
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Must have asthma.
Must be currently taking an inhaled corticosteroid.
Must be able to attend 7 clinic visits, of which up to 3 will be in the morning, and have lung function tests that are at least 60% of normal (AM FEV1 or PEF).
Have a historical or current FEV1 or PEF reversibility of \>=12%.
You may not be if
Has ever had life-threatening asthma (for example respiratory arrest, mechanical ventilation).
Has a current ear or respiratory tract infection.
Has ever had any other major illnesses (such as cystic fibrosis, heart problems, tuberculosis).
Clareo Health | A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma
